The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 pilot trial of RRx-001 as an anti-mucositis agent in patients with head and neck cancer treated with chemoradiation (PREVLAR).
 
Marcelo Raul Bonomi
Research Funding - Regeneron (Inst)
 
Dukagjin Blakaj
No Relationships to Disclose
 
David Sher
No Relationships to Disclose
 
Rafi Kabarriti
No Relationships to Disclose
 
Kyle Colvett
No Relationships to Disclose
 
Seth Reiner
No Relationships to Disclose
 
Vinita Takiar
No Relationships to Disclose
 
Matthew Biagioli
No Relationships to Disclose
 
Voichita C. Bar-Ad
No Relationships to Disclose
 
Sharad Goyal
No Relationships to Disclose
 
Brian C. Muzyka
No Relationships to Disclose
 
Kenneth J. Niermann
No Relationships to Disclose
 
Tony R. Reid
Employment - EpicentRx
Leadership - EpicentRx
Stock and Other Ownership Interests - EpicentRx
Speakers' Bureau - Genentech/Roche
Research Funding - Genentech/Roche
Travel, Accommodations, Expenses - EpicentRx
 
Bryan Oronsky
Employment - EpicentRx
Leadership - EpicentRx
Stock and Other Ownership Interests - EpicentRx
Travel, Accommodations, Expenses - EpicentRx
 
Nacer Abrouk
Consulting or Advisory Role - EpicentRx
Travel, Accommodations, Expenses - EpicentRx
 
Scott Caroen
Employment - EpicentRx
Stock and Other Ownership Interests - EpicentRx
Patents, Royalties, Other Intellectual Property - Scott Caroen is on patents relating to EpicentRx, Inc., technologies.
 
Pedro Cabrales
Research Funding - EpicentRx
 
Stephen T. Sonis
Employment - Biomodels; Primary Endpoint Solutions
Leadership - Biomodels; Immunity Health; Primary Endpoint Solutions; Primary Endpoint Solutions
Stock and Other Ownership Interests - BioInsight Diagnostics; Biomodels; Immunity Health; Inform Genomics
Consulting or Advisory Role - Biomodels (Inst); Primary Endpoint Solutions (Inst)
Research Funding - Biomodels (Inst); Primary Endpoint Solutions (Inst)
Patents, Royalties, Other Intellectual Property - Predictive genomics (Inst); Raman spectropscopy